Plamotamab

Tax included
Plamotamab (XmAb-13676) is a human bispecific antibody (bsAb) that binds CD3 and CD20. Plamotamab recruits cytotoxic T cells to kill CD20+ expressing tumor cells. Plamotamab induces a mild hematologic reaction (MR), and results in tumor regression in vivo.
MedChemExpress 
HY-P99776

Data sheet

Size
Multiple sizes
Reactivity
CD20; CD3
Application
Cancer-programmed cell death
CAS
2138442-31-4